Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Keke Nie"'
Publikováno v:
Thoracic Cancer, Vol 14, Iss 15, Pp 1355-1361 (2023)
Abstract Background The efficacy and safety of osimertinib combined with bevacizumab in non‐small cell lung cancer (NSCLC) patients with brain metastasis harboring epidermal growth factor receptor (EGFR) mutations have not been fully studied. Metho
Externí odkaz:
https://doaj.org/article/1f806dd5d92b4f44877bf1b180caaa15
Publikováno v:
Thoracic Cancer, Vol 11, Iss 1, Pp 8-14 (2020)
Background To compare the efficiency and toxicity of bevacizumab by intrapleural or intravenous infusion in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer (NSCLC). Methods Sensitizing mutation negative NS
Externí odkaz:
https://doaj.org/article/ed663cb83c404ad98d36a256eeb53ead
Autor:
Keke Nie, Ling Zhang, Yunhong You, Hongmei Li, Xiuhui Guo, Zhongfa Zhang, Chunling Zhang, Youxin Ji
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Objective: To study the efficacy and toxicity of irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma. Patients and methods: Previously untreated patients with cytologically or histologically confirmed me
Externí odkaz:
https://doaj.org/article/f0a0787460494739acb2f3b44904aee4
Autor:
Keke Nie MD, Xiuhui Guo MD, Yunhong You MD, Xingjun Zhuang MD, Chunling Zhang MD, Youxin Ji MD
Publikováno v:
Cancer Control, Vol 27 (2020)
Small-cell lung cancer (SCLC) is a recalcitrant cancer for its dismal prognosis although extensive research had been done. Four to 6 cycles platinum-based chemotherapy is the mainstay treatment for the extensive-stage disease; but the role of mainten
Externí odkaz:
https://doaj.org/article/d035a89b9d194c9ea948fcb08bf5ce53
Publikováno v:
Cancer Biology & Medicine, Vol 15, Iss 2, Pp 178-181 (2018)
Crizotinib, a small molecular tyrosine kinase inhibitor, manifests dramatic responses in patients with non-small cell lung cancer with echinoderm microtubule associated protein like 4-anaplastic lymphoma kinase (EML4-ALK) rearrangements. ALK gene poi
Externí odkaz:
https://doaj.org/article/2f72d5e2ef384ac3ad5677acaf7be609
Publikováno v:
Tissue and Cell. 82:102046
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7b57ea48680e2d9a3078acbb3e3392b
https://doi.org/10.1016/j.tice.2023.102046
https://doi.org/10.1016/j.tice.2023.102046
Publikováno v:
Thoracic Cancer, Vol 11, Iss 1, Pp 8-14 (2020)
Thoracic Cancer
Thoracic Cancer
Background To compare the efficiency and toxicity of bevacizumab by intrapleural or intravenous infusion in the management of malignant pleural effusion in patients with non-small-cell lung cancer (NSCLC). Methods Sensitizing mutation negative NSCLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f81f91ecd87d7bb2d0ed19156a451cd3
https://doaj.org/article/ed663cb83c404ad98d36a256eeb53ead
https://doaj.org/article/ed663cb83c404ad98d36a256eeb53ead
Publikováno v:
Cancer Control, Vol 27 (2020)
Cancer Control : Journal of the Moffitt Cancer Center
Cancer Control : Journal of the Moffitt Cancer Center
Small-cell lung cancer (SCLC) is a recalcitrant cancer for its dismal prognosis although extensive research had been done. Four to 6 cycles platinum-based chemotherapy is the mainstay treatment for the extensive-stage disease; but the role of mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1485207511b215f28d6f1ed7b32b7b
https://doaj.org/article/d035a89b9d194c9ea948fcb08bf5ce53
https://doaj.org/article/d035a89b9d194c9ea948fcb08bf5ce53
Supplemental Material, CCX-19-0211.R1_-_Registration for S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer—A Randomized Clinical Study by Keke Nie, Xiuhui Guo, Yunhong You, Xingjun Zhuang, Chunling Zhang and Youxin Ji in Cancer Cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cddda9e4abbb8d1a4bc1fce0b6240a
Supplemental Material, CCX-19-0211.R1_-_Checklist for S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer—A Randomized Clinical Study by Keke Nie, Xiuhui Guo, Yunhong You, Xingjun Zhuang, Chunling Zhang and Youxin Ji in Cancer Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::279d752c8a57e8587b80b66e9ce0f857